Skip to main content
S&P 5007,376.86+0.31%DOW51,285.73-0.46%NASDAQ24,579.42+1.09%BTC$75,946.00-0.25%ETH$2,243.57+0.21%GOLD$4,079.50-0.83%OIL$90.34-0.20%
Smart Investors Daily
SID Premium
EN

NASDAQ · ENSG

The Ensign Group, Inc.

Healthcare · Medical - Care Facilities

$181.08

Down-$1.31 (-0.72%)

Updated Nov 7, 2026, 5:31 AM

SID Score

6.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
10.02B
P/E ratio
30.45
Dividend yield
0.14%
52-week range
$141.58 – $218.00
Volume
292.12K
Avg. volume
398.39K

Price performance · ENSG

ENSG price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 6, 2026

ENSG closed at $181.08 after 21 trading sessions, up 5.40% for the selected period.

Last close
$181.08
Period change
+5.40%
Period low
$169.50
Period high
$188.31
Daily close
View OHLC price history
ENSG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 6, 2026$179.48$181.795$179.16$181.08292.12K
Nov 5, 2026$189.43$190.00$181.905$182.39397.56K
Nov 4, 2026$185.47$189.10$182.21$188.31527.22K
Nov 3, 2026$179.63$184.85$179.40$182.21613.9K
Nov 2, 2026$181.97$183.32$177.825$179.06408.33K
Oct 30, 2026$186.73$187.99$181.02$181.52411.63K
Oct 29, 2026$187.99$189.00$183.9125$186.32465.45K
Oct 28, 2026$178.23$187.25$175.34$184.11974.05K
Oct 27, 2026$175.20$176.99$168.43$169.50674.16K
Oct 26, 2026$177.25$180.75$175.8013$176.92490.01K
Oct 23, 2026$177.54$178.27$175.59$175.59248.73K
Oct 22, 2026$173.62$178.63$172.12$178.35307.8K
Oct 21, 2026$175.23$176.74$173.20$173.35286.58K
Oct 20, 2026$173.80$176.21$173.25$176.00328.97K
Oct 19, 2026$174.68$177.195$172.23$173.05277.41K
Oct 16, 2026$179.62$179.94$176.02$176.63288.15K
Oct 15, 2026$178.94$180.02$177.44$178.11343.8K
Oct 14, 2026$172.60$175.89$172.60$175.85292.37K
Oct 13, 2026$175.28$175.29$172.575$173.26275.16K
Oct 12, 2026$172.92$175.3894$172.92$173.92231.81K
Oct 9, 2026$171.36$173.7599$171.36$171.80205.33K

Latest ENSG news

The latest Smart Investors Daily articles mentioning ENSG.

Stock researchCompany · Overview

ENSG research

Overview

Company profile and research snapshot.

Company profile

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$208.67
Implied upside
—
Analysts
11
ENSG recent ratings
DateFirmRatingTarget
Nov 3, 2026RBC CapitalOutperform—
Oct 29, 2026OppenheimerOutperform—
Oct 29, 2026Truist SecuritiesHold—
Oct 29, 2026UBSBuy—
Jul 30, 2026Truist SecuritiesHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 31, 2026

ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gains

Healthcare services company The Ensign Group (NASDAQ:ENSG) fell short of the market’s revenue expectations in Q3 2026, but sales rose 14.5% year on year to $1.48 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.91 billion at the midpoint. Its GAAP profit of $1.76 per share was 2.8% below analysts’ consensus estimates.

Yahoo · Oct 30, 2026

Ensign Group (ENSG) Stock May Be Near Fair Value On Cash Flow

Ensign Group has delivered a strong run over the past few years, and the share price now reflects a lot of optimism. The live question is whether that price is in line with the cash flows the business is expected to generate. Over the last 5 years the stock has returned 143.3%, which puts real weight on whether those gains are backed by the underlying cash flow stream. The group runs a cash generative post-acute care model, so the value investors place on the shares may hinge on how...

Yahoo · Oct 30, 2026

The 5 most interesting analyst questions from The Ensign Group’s Q3 earnings call

The Ensign Group’s third quarter drew a positive market reaction despite missing Wall Street’s revenue and earnings per share expectations, as investors looked beyond headline numbers to underlying business momentum. Management attributed the quarter’s performance to continued gains in occupancy and skilled mix, with CEO Barry Port highlighting a “relentless patient-focused culture” and ongoing success in integrating new operations. The company’s clinical outcomes, validated by above-average qua

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By